NCT01380522
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
- Locations
-
- Algorithme Pharma Inc Montreal, Quebec, Canada
Clinical trial condition
To Determine the Bioequivalence Study Under Fed
Explore clinical trials studying To Determine the Bioequivalence Study Under Fed. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies